Skip to content

Search for:

About us
LITOSeek™
- LITOSeek Platform
- Translational Medicine
News
Contact

Search for:

ContactSebastien2023-08-24T11:57:39+02:00

Contactez-nous

Suisse

Novigenix SA
Phenyl building
Route de la Corniche 3
CH-1066 Epalinges
info@novigenix.com

formulaire

Nom*
First Last
E-mail*
Sujet
Message*

Novigenix AI

Novigenix AI is a pioneering TechBio delivering liquid biopsy multi-omic solutions powered by the LITOSeek™ AI-RNA analytics platform to accelerate early cancer detection and development of effective therapies for better patient outcomes.

Contact us

Route de la Corniche 3
Phenyl Building
CH-1066 Epalinges
Switzerland
partnerships@novigenix.com

Follow us on LinkedIn

Recent posts

Novigenix AI Spin-Out to Accelerate AI-Powered Immune Intelligence
Novigenix AI awarded EUR 1.8M in the groundbreaking BRECISE IHI Consortium to industrialize AI-powered liquid biopsy for prediction of immunotherapy response

Newsletter

Name*
First name Last name
E-mail*
Your e-mail Confirm your e-mail

COPYRIGHT 2026 NOVIGENIX AI | ALL RIGHTS RESERVED | PRIVACY POLICY | POWERED BY AGENCE-ACP |

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Learn more Ok

Tracking Cookies